Rising chronic diseases are driving expansion in the self-administered parenteral market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Self-Administered Parenteral Market During 2026–2030?

The size of the self-administered parenteral market has demonstrated consistent growth over recent years. This market is projected to expand from $25.84 billion in 2025 to $27.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.5%. Historically, this growth can be attributed to factors such as the increasing prevalence of chronic diseases, the widespread adoption of home-based treatments, significant advancements in prefilled syringes, heightened awareness of self-injection therapy, and the overall growth within the biopharma sector.

The self-administered parenteral market is projected for consistent expansion over the upcoming years, with its size anticipated to reach $32.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the forecast period include advancements in smart injector technologies, integration with mobile health applications, tailored dosage solutions, an increase in autoimmune and oncology therapies, and supportive regulatory frameworks for self-administration. Key trends identified for the forecast period encompass smart auto-injectors, the increasing adoption of prefilled syringes, on-demand therapy delivery, devices linked to telemedicine, and customized drug dosage solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

Which Important Drivers Are Guiding The Self-Administered Parenteral Market Growth?

The increasing occurrence of chronic diseases is expected to stimulate the growth of the self-administered parenteral market in the future. These diseases represent enduring medical conditions that generally advance slowly and often necessitate continuous management and treatment. Self-administered parenteral products are utilized in the management of chronic diseases, allowing individuals to oversee their treatment independently, which can considerably enhance adherence compared to oral medication. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This figure is anticipated to more than double, reaching 1.3 billion people by 2050. Consequently, the rising incidence of chronic diseases is a key factor driving the expansion of the self-administered parenteral market.

Which Segments Define The Self-Administered Parenteral Market Segment Structure?

The self-administered parenteral market covered in this report is segmented –

1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products

2) By Usage: Disposable, Reusable

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels

4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Subsegments:

1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes

2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors

3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors

4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices

What Trends Are Influencing The Evolution Of The Self-Administered Parenteral Market?

Leading companies in the self-administered parenteral market are prioritizing the development of innovative products, like the UDENYCA autoinjector, to offer greater choice and control, ultimately improving patient access to treatment. An autoinjector is a medical device designed for delivering a singular dose of a specific drug, characterized by an intuitive design that triggers administration immediately and reliably through push-on-skin activation. For example, in May 2023, Coherus BioSciences Inc., a US-based biotech company, launched the UDENYCA autoinjector, a self-administered parenteral medication, within the US. The UDENYCA Autoinjector is a single-dose, prefilled autoinjector providing patients with an alternative administration option for pegfilgrastim. It is engineered to be intuitive, with administration activated by push-on-skin, ensuring reliable and immediate delivery of a full pegfilgrastim dose. Additionally, it features several user-friendly aspects that promote successful delivery, such as fast dosing, an intuitive design, dual coverage, at-home and in-office utility, and a reduction in the risk of febrile neutropenia.

Who Are The Established Players Within The Self-Administered Parenteral Market?

Major companies operating in the self-administered parenteral market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A S, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N V, Terumo Corporation, Catalent Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, ScPharmaceuticals Inc., Fresenius Kabi AG

Get The Full Self-Administered Parenteral Market Report:

https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

Which Region Leads The Self-Administered Parenteral Market In Overall Market Size?

North America was the largest region in the self-administered parenteral market in 2025. The regions covered in the self-administered parenteral market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Self-Administered Parenteral Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

Browse Through More Reports Similar to the Global Self-Administered Parenteral Market 2026, By The Business Research Company

Parenteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

Small Volume Parenteral Market Report

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Large Volume Parenteral Lvp Market Report

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795